AAPLMay 15, 2026 at 1:13 PM UTCTechnology Hardware & Equipment

iPhone Sales Momentum Continues, But Regulatory and Cost Headwinds Loom

Read source article

What happened

CounterPoint research indicates iPhone sales remain strong across key markets, reinforcing Apple's near-term demand narrative. However, the DeepValue master report cautions that this strength is already priced in at a 35x P/E, while regulatory remedies in the EU and U.S. threaten the high-margin Services business that supports the valuation. Apple's own disclosures confirm supply constraints and rising component costs are expected to intensify, potentially compressing Products gross margin from 38.7%. The stock's current level leaves little margin of safety against these structural risks, even with robust buyback support. Investors should view the positive sales data as confirmation of the bull case demand assumption, not a reason to ignore the binding downside catalysts.

Implication

The CounterPoint data aligns with the DeepValue report's base case of resilient iPhone demand, particularly in Greater China, and supports the bull scenario's upgrade cycle thesis. However, it does not mitigate the two primary downside drivers: (1) ongoing EU and U.S. legal actions that could reset App Store take rates, directly compressing 76.7% Services margin, and (2) intensifying supply constraints and component costs that Apple warns may materially impact demand and gross margin. At 35x P/E, the market is pricing in minimal disruption to Services economics, yet Apple's own filings show binding cease-and-desist orders and a €500m fine already in place. The near-term sales strength may tempt investors to overlook these headwinds, but the risk-reward remains skewed to the downside unless regulatory outcomes stabilize below $250. The $100b buyback provides a floor, but it becomes a leverage if earnings decline. The next 90 days are critical: monitor the next 10-Q for Greater China sustainability and Products gross margin trends, and any rate-setting progress in the U.S. Epic remedy docket.

Thesis delta

Stronger-than-expected iPhone sales data supports the bull case demand assumption but does not alleviate binding regulatory or margin risks; the core thesis remains that at 35x P/E, Services economics are overpriced relative to the growing probability of a multi-region take-rate reset and intensifying cost pressures.

Confidence

Medium